Galectin Therapeutics Inc [NASDAQ: GALT] Sees Decrease in Stock Value
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Galectin Therapeutics Inc’s filing revealed that its Director ELDRED KARY acquired Company’s shares for reported $1300.0 on Oct 23 ’24.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Galectin Therapeutics
Galectin Therapeutics Inc’s recent filing unveils that its Director ELDRED KARY acquired Company’s shares for reported $1300.0 on Oct 23
Galectin Therapeutics Inc’s filing revealed that its Director ELDRED KARY acquired Company’s shares for reported $1300.0 on Oct 23 ’24.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Galectin Therapeutics
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.